Steps (from presentation): 
1. Sequencing Data Generation
2. Basecalling/Denoising
3. Read Mapping - the process of aligning short DNA sequences (reads) from a sample to a reference genome to determine their origin. 
   It works by comparing the reads to a known database, accounting for possible mismatches or errors
4. Downstream Analysis - refers to the steps taken after raw genomic data has been processed. It involves tasks like identifying 
   genetic variants, analyzing gene expression, classifying species in a sample, or linking genes to biological functions. 

Study #1 -  A population-scale analysis of 36 gut microbiome studies reveals universal species signatures for common diseases
-----------------------------------------------------------------------------------------------------------------------------
about the Dataset:

Sample type: fecal

Number of patients: 3728 patients with 28 disease/unhealthy statuses and 2586 healthy controls 
       - from 13 provinces, no abnormal BMI

Diseases: breast (BC), colorectal (CRC), yCRC (young onset), oCRC (old onset), athero-sclerotic cardiovascular disease(ACVD),
          atrial fibrillation (AF), bone mass loss (BL), carotid atherosclerosis (CA), hypertension (HTN), prehypertension (pHTN), 
          metabolically unhealthy obese (MUO), obesity (OB), type 2 diabetes (T2D), prediabetes (pT2D), treatment-naive type 2 diabetes(tnT2D), 
          Crohn's disease(CD), ulcerative colitis (UC), irritable bowel syndrome (IBS), polycystic ovarian syndrome (PCOS), 
          ankylosing spondylitis (AS), Behcet's disease(BD), Graves' disease (GD), myasthenia gravis (MG), rheumatoid arthritis (RA), 
          systemic lupus erythematosus (SLE), Vogt-Koyanagi-Harada diseases (VKH), pulmonary tuberculosis (PT), liver cirrhosis (LC), 
          autism spectrum disorder (ASD), schizophrenia (SCZ),Parkinson's disease (PD), end-stage renal disease (ESRD)

Bacteria: by phylum: Bacteroidetes, Firmicutes, Proteobacteria, Actinobacteria, Fusobacteria, Verrucomicrobia, others
          by genus: Phocaeicola, Bacteroides, Prevotella, Faecalibacterium, Alistipes, Lachnospiraceae_unk, Roseburia, Clostridium, 
                    Ruminococcus, Bifidobacterium, Lachnospira, Mediterraneibacter, Parabacteroides, Blautia, Escherichia, 
                    Clostridia_unclassified, Megamonas, Ruminococcaceae_unk, Phascolarctobacterium, other
          by species: Phocaeicola vulgatus, Prevotella copri clade A, Faecalibacterium prausnitzii, Bacteroides uniformis, 
                    Phocaeicola plebeius, Bacteroides stercoris, Phocaeicola dorei, Alistipes putredinis, Eubacterium rectale,
                    Escherichia coli, Bacteroides ovatus, Bacteroides fragilis, Phocaeicola coprocola, Prevotella copri clade C,
                    Megamonas funiformis, Ruminococcus bromii, Bacteroides thetaiotaomicron, Roseburia faecis, Phocaeicola massiliensis,
                    Parabacteroides distasonis, other
adundance, alerations in abundance based on disease status

-----------------------------------------------------------------------------------------------------------------------------
Data Preprocessing/Transformation:
fastp - applied to Raw Metagenomic Data; removal of low-quality (quality score <20), low-complexity (more than 5 'N' bases) and adapter-containing reads (shorter than 45 bases)
Bowtie2 - removal of non-human reads (mapping against reference human genome)
MetaPhlAn 4 - conversion of reads into species-level genome bins (SGBs) 
arcsine-aquare root transformation - proportional comparability across studies

Feature Selection: 
disease-associated microbial signatures - multivariate MaAsLin 2 analysis (q-value < 0.05; adjustments for demographic confounders (age, sex, BMI))
species-level abundance profiles - Jensen-Shannon divergence & PAM clustering (determination of optimal clusters) 

Dataset Division (Training, Testing): 
10x Cross Validation

ML Approach:
Random Forest Model - analysis of disease correlation with microbial taya to estimate GMHI (Gut Microbiome Health Index); averaging predictions from 10 classifiers
LASSO Analysis - fine-tuning and constrain features

Validation:
Wilcoxon rank-sum tests & Benjamini Hochberg adjustment for q-values
ROC (receiver operating characteristic) analysis (R pROC package); main measure: AUC (area under curve)



Study #2 - Consistent signatures in the human gut microbiome of old- and young-onset colorectal cancer
------------------------------------------------------------------------------------------------------
about the Dataset: 
[...]
------------------------------------------------------------------------------------------------------
[...]



Study #3 - Microbiome confounders and quantitative profiling challenge predicted microbial targets in colorectal cancer development
-----------------------------------------------------------------------------------------------------------------------------------
about the Dataset:
[...]
-----------------------------------------------------------------------------------------------------------------------------------
Data Preprocessing/Transformation:
Relative Microbiome Matrix (RMP) - 
CLR (center-log-ratio) Transformation - 

Feature Selection: 
Biomarker Selection - relevant microbial taxa at species and genus level were picked out
Dirichlet Multinomial Model - enterotyping/determine community types (Bact1, Bact2, Prev, and Rum clusters)
Spearman and Kendall's tau correlations - determination of association across species abundances, fecal calprotectin, moisture content

Dataset Division (Training, Testing): 
subdivision into 2 cohorts - LCPM Project, FGFP Project
1. LCPM Project - cohort with data from patients with different stages of CRC (healthy, polyps, CRC)
2. FGFP Project - 

ML Approach:
Generalized Linear Models (GLMs)
Nested Model Comparison 

Validation:
